Active Inhibitory Effect of Nafamostat Mesylate against the Elevation of Plasma Myeloperoxidase during Hemodialysis

Kazuto Inose,Kumeo Ono,Akiyasu Tsutida,Masayuki Onai,Minoru Komai,Kiyosi Uehara,Shintaro Yano,Takuji Naruse

Active Inhibitory Effect of Nafamostat Mesylate against the Elevation of Plasma Myeloperoxidase during Hemodialysis

1997

Kazuto Inose
Kumeo Ono
Akiyasu Tsutida
Masayuki Onai
Minoru Komai
Kiyosi Uehara
Shintaro Yano
Takuji Naruse

Plasma levels of myeloperoxidase (MPO) were compared between hemodialysis (HD) sessions using heparin and those using nafamostat mesylate (NM) as an anticoagulant by an enzyme immunoassay established

Keywords:

Anticoagulant
Nafamostat
Immunoassay
Endocrinology
Internal medicine
Heparin
Myeloperoxidase
Hemodialysis
Elastase
Medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations